Journal: Frontiers in Pharmacology
Article Title: Screening and evaluation of metabolites binding PRAS40 from Erxian decoction used to treat spinal cord injury
doi: 10.3389/fphar.2024.1339956
Figure Lengend Snippet: Palmatine activates autophagic flux by PRAS40/mTOR pathway. (A) Western blot analysis for determining the expression of p-mTOR, mTOR, p-PRAS40, PRAS40, and LC3 (n = 3) (B) Quantification of the ratio of LC3-Ⅱ to LC3-Ⅰ(∗∗ p < 0.01), (C) p-PRAS40 to PRAS40 (∗ p < 0.01), and (D) p-mTOR to mTOR(∗ p < 0.01, ∗∗∗∗ p < 0.001). The data are depicted as the mean ± SEM.
Article Snippet: For reference, Indole (No. I104724 ) and palmatine chloride (No. P274975) were acquired from Aladdin Co., Ltd (Shanghai, China).
Techniques: Western Blot, Expressing